Certain factors may increase the risk of pyrazinamide-induced hepatotoxicity. These include pre-existing liver conditions, concurrent use of other hepatotoxic drugs, and alcohol consumption. The risk also increases with higher doses of pyrazinamide. Monitoring of liver function tests is recommended during treatment to detect early signs of liver dysfunction.
